Key Developments: OraSure Technologies Inc (OSUR.O)
4.43USD
20 May 2013
$0.02 (+0.45%)
$4.41
$4.40
$4.45
$4.34
302,068
428,718
$14.01
$4.24
Latest Key Developments (Source: Significant Developments)
OraSure Technologies Inc Issues Q2 2013 Revenue Guidance Above Analysts' Estimates; Issues Q2 2013 EPS Guidance Below Analysts' Estimates
OraSure Technologies Inc announced that for the second quarter of 2013, it expects consolidated net revenues to range from $23.5 to $24.0 million and is projecting a consolidated net loss of approximately $0.15 - $0.16 per share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $23.4 million and EPS of $(0.14) for the second quarter of 2013. Full Article
OraSure Technologies Inc Issues Q1 2013 Guidance Below Analysts' Estimates
OraSure Technologies Inc announced that for first quarter of 2013, it expects total consolidated net revenues to range from $20.0-$21.0 million and is projecting a consolidated net loss of approximately $0.18-$0.19 per share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $29 million and EPS of $(0.05) for first quarter of 2013. Full Article
OraSure Technologies Inc Issues Q4 2012 Guidance Below Analysts' Estimates
OraSure Technologies, Inc. announced that it expects total consolidated revenues to range from $20.5 million to $21.0 million and is projecting a consolidated net loss of approximately $0.13-$0.15 per share (EPS) for the fourth quarter of 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $24.0 million and EPS of $(0.08) for the fourth quarter of 2012. Full Article
OraSure Technologies, Inc. Issues Q3 2012 Guidance
OraSure Technologies, Inc. announced that it expects total consolidated revenues to range from $22.0 million to $22.5 million and is projecting a consolidated net loss of approximately $0.07-$0.08 per share for the third quarter of 2012. Full Article
OraSure Technologies, Inc. Announces Closing Of Underwritten Offering of Common Stock
OraSure Technologies, Inc. announced the closing of its previously announced public offering of common stock. As a result, the Company issued a total of 6,100,000 shares in the offering at a price of $12.30 per share. After the underwriting discounts and estimated offering expenses, OraSure received net proceeds of approximately $70.2 million. Citigroup and Jefferies served as joint book-running managers and Canaccord Genuity, Stephens Inc., ThinkEquity LLC and JMP Securities served as co-managers for the offering. The shares described above were sold by OraSure pursuant to a registration statement previously filed with and subsequently declared effective by the Securities and Exchange Commission. The Company expects to use the net proceeds of this offering for general corporate purposes. Full Article
OraSure Technologies, Inc. Prices Underwritten Offering Of Common Stock
OraSure Technologies, Inc. announced the pricing of an underwritten offering of 6,100,000 shares of its common stock at a price of $12.30 per share. After the underwriting discount and estimated offering expenses, OraSure expects to receive net proceeds of approximately $70.2 million. In addition, OraSure has granted the underwriters a 30-day option to purchase up to an additional 915,000 shares of its common stock. The offering is expected to close on July 16, 2012, subject to customary closing conditions. Citigroup and Jefferies served as joint book-running managers and Canaccord Genuity, Stephens Inc., ThinkEquity LLC and JMP Securities served as co-managers for the offering. Full Article
OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock
OraSure Technologies, Inc. announced it has commenced an underwritten public offering of its common stock in an amount of up to $75.0 million. Citigroup and Jefferies are acting as joint book-running managers. Canaccord Genuity, Stephens Inc., ThinkEquity LLC and JMP Securities are acting as co-managers. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the final size or terms of the offering. Full Article
OraSure Technologies, Inc. Receives FDA Approval Of OraQuick In Home HIV Test
OraSure Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Company's OraQuick In-Home HIV Test for sale directly to consumers in the over-the-counter (OTC) market – making it the first and only rapid OTC HIV test approved in the U.S. The OraQuick In-Home HIV Test can detect antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes. It is the first rapid diagnostic test for any infectious disease that has been approved by the FDA for sale over the counter. Full Article
OraSure Technologies, Inc. Issues Q2 2012 Guidance Below Analysts' Estimates
OraSure Technologies, Inc. announced that it expects total consolidated revenues for the second quarter of 2012 to range from $22.0-$22.5 million and is projecting a consolidated net loss of approximately $0.09-$0.10 per share (EPS) for the second quarter of 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $23.8 million and EPS of $(0.04) for the second quarter of 2012. Full Article
OraSure Technologies, Inc. Issues Q1 2012 Guidance Below Analysts' Estimates
OraSure Technologies, Inc. announced that for the first quarter of 2012, it expects total consolidated revenues to range from $20.5 to $21.0 million and a net loss of approximately $0.08 - $0.09 per share for the first quarter of 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $23.05 million and EPS of $(0.04) for the first quarter of 2012. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
